CPMG Inc
- SEC CIK
- 0001372218
- Latest filing
- May 15, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 5
- 0 vs. Q4 2021
- Portfolio value
- $596.2M
- +$53.9M (+9.9%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | COM | 10,918,393 | $382.0M | 64.1% | −304,269−2.7% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 2,896,901 | $94.9M | 15.9% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 8,218,467 | $88.3M | 14.8% | −260,323−3.1% | Reduced | History |
| APENApollo Endosurgery, Inc. | COM | 3,905,225 | $23.6M | 4.0% | +26,483+0.7% | Added | History |
| iShares S&P 500 Value ETF464287408 | ETF | 46,500 | $7.24M | 1.2% | +46,500 | New | – |
Sold out since Q4 2021 (1)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | 18,704 | $7.44M | 1.4% | – |